• HOME
  • SUPPORT
  • CONTACT US
  • LOGIN / REGISTER
LOGIN OR REGISTER
Course Library

Featured Courses

This and other images are RealCME property

Innovative Strategies for Second-Line Therapy for SCLC

Oncology

Course Description: This module covers Small Cell Lung Cancer (SCLC), including its biology, clinical presentation, diag...

This and other images are RealCME property

Identifying and Escalating Care for Uncontrolled Asthma

Pulmonary Disease

Course Description: Learn how to recognize uncontrolled asthma, make escalation and referral decisions, bridge the gap b...

This and other images are RealCME property

Specialty Specific Guidance: A Cardiologist's Guide to Using GLP-1 Receptor Agonists in Patients who are Obese

Weight Management

Course Description: This program trains cardiologists to effectively integrate GLP-1 RAs into their practice by identify...

This and other images are RealCME property

Specialty Specific Guidance: An OB/GYN Professionals Guide to Using GLP-1 Receptor Agonists in Patients with Overweight or Obesity to Optimize Women's Health Across the Lifespan

Weight Management

Course Description: This program equips OB/GYNs to manage patient weight and metabolic health by integrating GLP-1 recep...

Course Filtering Options

ALL COURSES
FEATURED
CURRICULA
ARCHIVED
  • By Course Topics
  • By Publish Date
  • By Course Title

ARCHIVED PUBLISHED COURSES

The Anti-seizure Medication Landscape and Their Effect on Non-seizure Symptoms

LAUNCH DATE: 30-Sep-2024

EXPIRATION DATE: 31-Dec-2025

Neurology

CREDITS

0.25 AMA PRA Category 1 Credit(s)™

The Impact of Non-seizure Symptoms in Patients with Developmental and Epileptic Encephalopathies

LAUNCH DATE: 30-Sep-2024

EXPIRATION DATE: 31-Dec-2025

Neurology

CREDITS

0.25 AMA PRA Category 1 Credit(s)™

Therapeutic Options for Achieving Realistic Management Goals with Your IBS Patients

LAUNCH DATE: 23-Feb-2016

EXPIRATION DATE: 23-Feb-2017

Gastroenterology

CREDITS

1 ANCC Contact Hours

1 AMA PRA Category 1 Credit(s)™

Transforming Treatment of Advanced/Metastatic Cutaneous Squamous Cell Carcinoma: Current Treatment

LAUNCH DATE: 13-Nov-2018

EXPIRATION DATE: 12-Nov-2019

RELATED COURSES

  • Transforming Treatment of Advanced/Metastatic Cutaneous Squamous Cell Carcinoma: The Immune System and the Role of PD-1
  • Transforming Treatment of Advanced/Metastatic Cutaneous Squamous Cell Carcinoma: PD-1 Inhibitors for the Treatment of cSCC
Oncology

CREDITS

0.25 AMA PRA Category 1 Credit(s)™

Transforming Treatment of Advanced/Metastatic Cutaneous Squamous Cell Carcinoma: PD-1 Inhibitors for the Treatment of cSCC

LAUNCH DATE: 13-Dec-2018

EXPIRATION DATE: 12-Dec-2019

RELATED COURSES

  • Transforming Treatment of Advanced/Metastatic Cutaneous Squamous Cell Carcinoma: The Immune System and the Role of PD-1
  • Transforming Treatment of Advanced/Metastatic Cutaneous Squamous Cell Carcinoma: Current Treatment
Oncology

CREDITS

0.25 AMA PRA Category 1 Credit(s)™

Transforming Treatment of Advanced/Metastatic Cutaneous Squamous Cell Carcinoma: The Immune System and the Role of PD-1

LAUNCH DATE: 29-Oct-2018

EXPIRATION DATE: 28-Oct-2019

RELATED COURSES

  • Transforming Treatment of Advanced/Metastatic Cutaneous Squamous Cell Carcinoma: Current Treatment
  • Transforming Treatment of Advanced/Metastatic Cutaneous Squamous Cell Carcinoma: PD-1 Inhibitors for the Treatment of cSCC
Oncology

CREDITS

0.25 AMA PRA Category 1 Credit(s)™

Treating to Target with Novel Agents in Rheumatoid Arthritis

LAUNCH DATE: 16-May-2017

EXPIRATION DATE: 16-May-2018

RELATED COURSES

  • Tailoring Approaches to Management in Patients with Rheumatoid Arthritis: What's New?
  • Novel Personalized Management Approaches in Rheumatoid Arthritis
Rheumatology

CREDITS

0.5 AMA PRA Category 1 Credit(s)™

Treatment Intensification: How to Incorporate GLP-1 RA and Basal Insulin in Practice

LAUNCH DATE: 16-May-2017

EXPIRATION DATE: 16-May-2018

RELATED COURSES

  • Considerations in the use of GLP-1 RA and Basal Insulin in Clinical Practice
  • GLP-1 RA and Basal Insulin: Individualizing Therapy for Clinical Practice
Endocrinology

CREDITS

0.75 AMA PRA Category 1 Credit(s)™

Type 2 Inflammation in Asthma: Considerations for Targeted Therapy

LAUNCH DATE: 20-Dec-2018

EXPIRATION DATE: 20-Dec-2019

RELATED COURSES

  • Exploring the Role of Type 2 Inflammation in Uncontrolled Asthma
  • Grand Rounds -- Can You Do It Better? A Unique Approach to Enabling Improved Asthma Management
Pulmonary Disease

CREDITS

0.5 AMA PRA Category 1 Credit(s)™

Understanding Obesity Management Through the Lens of Cultural Humility

LAUNCH DATE: 29-Jul-2024

EXPIRATION DATE: 28-Jul-2025

Weight Management

CREDITS

1.00 AMA PRA Category 1 Credit(s)™

1.00 AAFP Prescribed Credit(s)

Understanding the Importance of Screening and Utility of Clinical Assessment Tools for Early Stages of Alzheimer's Disease

LAUNCH DATE: 24-Jan-2022

EXPIRATION DATE: 24-Jan-2023

RELATED COURSES

  • A Closer Look Into Validated Cognitive Assessment Tools for Multiple Domains of Alzheimer's Disease
  • Improving Screening and Diagnosis of Alzheimer's Disease
  • Improving Screening and Diagnosis of Alzheimer's Disease
Neurology

CREDITS

0.5 AMA PRA Category 1 Credit(s)™

Unraveling Prurigo Nodularis - Pathogenesis, Evaluation, and Impact on Quality of Life

LAUNCH DATE: 22-Dec-2023

EXPIRATION DATE: 22-Dec-2024

RELATED COURSES

  • Optimizing Care for Prurigo Nodularis - Evidence-Based Treatment Approaches and Personalized Strategies
Dermatology

CREDITS

0.25 AMA PRA Category 1 Credit(s)™

Updates on the Management of Motor Signs and Symptoms of Parkinson’s Disease

LAUNCH DATE: 07-Apr-2020

EXPIRATION DATE: 07-Apr-2021

Neurology

CREDITS

0.5 AMA PRA Category 1 Credit(s)™

Using Real-World Patient Scenarios and Simulations to Overcome Barriers to Appropriate Use of Oral Anticoagulants-Provoked VTE

LAUNCH DATE: 28-Jun-2019

EXPIRATION DATE: 28-Jun-2020

Pulmonary Disease

CREDITS

.50 AMA PRA Category 1 Credit(s)™

.50 ANCC Contact Hours

0.50 ACPE

Using Real-World Patient Scenarios and Simulations to Overcome Barriers to Appropriate Use of Oral Anticoagulants-Unprovoked VTE

LAUNCH DATE: 27-Jun-2019

EXPIRATION DATE: 27-Jun-2020

Pulmonary Disease

CREDITS

.50 AMA PRA Category 1 Credit(s)™

.50 ANCC Contact Hours

0.50 ACPE

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next
  • Cookie Policy
Powered By RealCME © 2007-2026 HealthCourse, Inc. All rights reserved.
  • Support
  • Privacy Policy
  • Terms of Service
  • Contact Us
Error
Coming Soon

Coming Soon

Schedule an event with a Standardized Patient
×